Catalyst Pharmaceuticals(CPRX) - 2024 Q1 - Quarterly Report

[Mark One] ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Title of Each ClassTicker SymbolName of Exchange on Which Registered Common Stock, par value $0.001 per share CPRX NASDAQ Capital Market UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q For the Quarterly Period Ended March 31, 2024 Table of Contents Emerging growth company ☐ The Company has an operating lease agreement for its corporate office. The lease includes an option to ...